Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein kinase C negatively modulated by phorbol ester.

M Inagaki, M Hagiwara, M Saitoh

    FEBS Letters
    |July 7, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes.

    The Journal of experimental medicine·1995
    Same author

    Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice.

    European journal of immunology·1995
    Same author

    Purification and characterization of a novel protein activator of Ca2+/calmodulin-dependent protein kinase I.

    Biochemical and biophysical research communications·1995
    Same author

    Effect of KN-62, Ca2+/calmodulin-dependent protein kinase II inhibitor, on adriamycin resistance of human ovarian cancer cells.

    Biochemical and biophysical research communications·1995
    Same author

    The regulatory region of calcium/calmodulin-dependent protein kinase I contains closely associated autoinhibitory and calmodulin-binding domains.

    The Journal of biological chemistry·1995
    Same author

    Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.

    The Journal of pharmacology and experimental therapeutics·1995

    12-O-tetradecanoylphorbol-13-acetate (TPA) irreversibly inhibits protein kinase C activity, requiring phospholipid. MgATP addition protected the enzyme, suggesting TPA and phospholipid influence the nucleotide-binding site.

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Enzymology

    Background:

    • Protein kinase C (PKC) is a key signaling enzyme involved in various cellular processes.
    • Understanding the regulation of PKC activity is crucial for deciphering cellular signaling pathways.

    Purpose of the Study:

    • To investigate the effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) and phospholipids on protein kinase C activity.
    • To elucidate the mechanism underlying TPA-induced inhibition of PKC.

    Main Methods:

    • Enzyme assays were performed to measure the ATP/phosphotransferase activity of protein kinase C.
    • The influence of TPA, phospholipids, Ca2+, diacylglycerol, and MgATP on enzyme activity was assessed.
    • Comparative studies were conducted with the catalytic subunit of cAMP-dependent protein kinase.

    Related Experiment Videos

    Main Results:

    • Pretreatment with TPA and phospholipid completely and irreversibly inhibited protein kinase C's ATP/phosphotransferase activity.
    • TPA-induced inactivation was dependent on the presence of phospholipid; TPA alone did not cause inactivation.
    • Calcium ions (Ca2+) and diacylglycerol mimicked the action of TPA.
    • This inhibitory effect was specific to PKC, as TPA did not accelerate the inactivation of cAMP-dependent protein kinase by phospholipid.
    • The addition of MgATP fully protected protein kinase C from TPA-induced inactivation in the presence of phospholipid.

    Conclusions:

    • TPA, in conjunction with phospholipids, acts as an irreversible inhibitor of protein kinase C.
    • The findings suggest that TPA and phospholipids likely interact with or influence the nucleotide-binding site of protein kinase C.
    • This regulatory mechanism highlights the complex control of protein kinase C signaling pathways.